Suppr超能文献

2024年与初级保健相关的顶级研究:来自PEER团队。

Top studies of 2024 relevant to primary care: From the PEER team.

作者信息

Moe Samantha S, Thomas Betsy S, Perry Danielle, Braschi Émélie, Dugré Nicolas, Falk Jamie, Lindblad Adrienne J, Paige Alli, Allan G Michael

机构信息

Clinical Evidence Expert at the College of Family Physicians of Canada (CFPC).

Clinical Evidence Expert at the CFPC and Assistant Adjunct Professor in the Department of Family Medicine at the University of Alberta (U of A) in Edmonton.

出版信息

Can Fam Physician. 2025 May;71(5):309-313. doi: 10.46747/cfp.7105309.

Abstract

OBJECTIVE

To identify and summarize the most impactful medical articles published in 2024 relevant to primary care.

SELECTING THE EVIDENCE

Randomized controlled trials and meta-analyses relevant to primary care were identified by the PEER (Patients, Experience, Evidence, Research) team, a Canadian evidence-based medicine research group with a focus on primary care. The table of contents of major medical journals were reviewed as well as medical email alert services. The articles were ranked by the PEER team and selected studies were summarized.

MAIN MESSAGE

Articles addressed various clinical areas in primary care. Topics included a behavioural strategy to reduce chronic benzodiazepine use for insomnia; the roles of β-blockers and colchicine after myocardial infarction; the effect of intensive blood pressure lowering on major cardiovascular outcomes; the effect of vitamin D on fracture prevention; walking for preventing recurrent back pain; testosterone for sexual dysfunction; methotrexate for osteoarthritis; dual antiplatelet use in patients with stable coronary artery disease and atrial fibrillation; and expanding indications for glucagon-like peptide-1 agonists. Four studies that evaluated the impact of screening and guideline-adherence strategies on patient outcomes were honourable mentions.

CONCLUSION

Several clinical trials and meta-analyses published in 2024 were relevant to primary care, particularly in the areas of insomnia, cardiology, and musculoskeletal disorders.

摘要

目的

识别并总结2024年发表的与初级保健相关的最具影响力的医学文章。

选择证据

与初级保健相关的随机对照试验和荟萃分析由PEER(患者、经验、证据、研究)团队识别,该团队是一个专注于初级保健的加拿大循证医学研究小组。主要医学期刊的目录以及医学电子邮件提醒服务都进行了审查。文章由PEER团队进行排名,并对选定的研究进行了总结。

主要信息

文章涉及初级保健的各个临床领域。主题包括减少慢性苯二氮䓬类药物用于失眠的行为策略;心肌梗死后β受体阻滞剂和秋水仙碱的作用;强化降压对主要心血管结局的影响;维生素D对预防骨折的作用;步行预防复发性背痛;睾酮治疗性功能障碍;甲氨蝶呤治疗骨关节炎;稳定型冠状动脉疾病和心房颤动患者使用双重抗血小板治疗;以及扩大胰高血糖素样肽-1激动剂的适应症。四项评估筛查和指南依从性策略对患者结局影响的研究获得了荣誉提及。

结论

2024年发表的几项临床试验和荟萃分析与初级保健相关,特别是在失眠、心脏病学和肌肉骨骼疾病领域。

相似文献

7
Exercise for intermittent claudication.间歇性跛行的运动疗法
Cochrane Database Syst Rev. 2017 Dec 26;12(12):CD000990. doi: 10.1002/14651858.CD000990.pub4.

本文引用的文献

1
Colchicine in Acute Myocardial Infarction.秋水仙碱与急性心肌梗死
N Engl J Med. 2025 Feb 13;392(7):633-642. doi: 10.1056/NEJMoa2405922. Epub 2024 Nov 17.
6
Beta-Blocker Interruption or Continuation after Myocardial Infarction.心肌梗死后β受体阻滞剂的中断或继续。
N Engl J Med. 2024 Oct 10;391(14):1277-1286. doi: 10.1056/NEJMoa2404204. Epub 2024 Aug 30.
10
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity.替尔泊肽治疗阻塞性睡眠呼吸暂停和肥胖。
N Engl J Med. 2024 Oct 3;391(13):1193-1205. doi: 10.1056/NEJMoa2404881. Epub 2024 Jun 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验